Novavax NVAX
$ 8.66
-0.51%
Quarterly report 2024-Q3
added 11-12-2024
Novavax Cash Flow 2011-2024 | NVAX
Annual Cash Flow Novavax
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
-714 M | -416 M | 323 M | -42.5 M | -137 M | -185 M | -144 M | -259 M | -126 M | - | - | -18.2 M | -23.6 M |
Depreciation & Amortization |
41 M | 29 M | 13 M | 4.3 M | 5.1 M | 7.4 M | 7.6 M | 7.7 M | 5.1 M | 4.4 M | 2.6 M | 1.7 M | 1.6 M |
Accounts Payables |
133 M | 217 M | 127 M | 54.3 M | 2.91 M | 9.3 M | 5.61 M | 5.68 M | 11.9 M | 12.9 M | 5.98 M | 3.23 M | 2.64 M |
Accounts Receivables |
297 M | 82.4 M | 455 M | 262 M | 7.5 M | - | - | - | 1.45 M | 7.51 M | 1.91 M | 1.01 M | 1.96 M |
Total Inventories |
41.7 M | 36.7 M | 8.87 M | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Quarterly Cash Flow Novavax
2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow |
- | - | - | - | - | -326 M | - | -298 M | -259 M | -88.5 M | - | 665 M | 807 M | 663 M | - | 86 M | 92.5 M | -23.1 M | - | -113 M | -80.6 M | -50.6 M | - | -140 M | -106 M | -66.1 M | - | -101 M | -56.9 M | -44.5 M | - | -194 M | - | - | - | - | - | - | - | - | - | -20.4 M | - | - | - | -10.6 M | - | -15 M | -10.3 M | -4.22 M | - | -20.8 M | -17.4 M | -9.04 M |
Depreciation & Amortization |
- | - | - | - | - | 9.04 M | - | 21.8 M | 13.5 M | 6.76 M | - | 8.99 M | 4.73 M | 2.32 M | - | 500 K | 300 K | 925 K | - | 500 K | 3.86 M | 1.94 M | - | 6.18 M | 4.14 M | 2.08 M | - | 7.7 M | 4.17 M | 2.11 M | - | 6.29 M | 4.07 M | 1.95 M | - | 4.35 M | 2.8 M | 1.31 M | - | 3 M | 1.96 M | 980 K | - | 1.64 M | 961 K | 449 K | - | 1.22 M | 810 K | 404 K | - | 1.2 M | 788 K | 389 K |
Accounts Payables |
57.5 M | 80 M | 133 M | 102 M | 87.2 M | 125 M | 217 M | 145 M | 386 M | 135 M | 127 M | 59.6 M | 74 M | 114 M | 54.3 M | 54.3 M | 54.3 M | 54.3 M | 2.91 M | 2.91 M | 2.91 M | 2.91 M | 9.3 M | 9.3 M | 9.3 M | 9.3 M | 5.61 M | 5.61 M | 5.61 M | 5.61 M | 5.68 M | 5.68 M | 5.68 M | 5.68 M | 11.9 M | 11.9 M | 11.9 M | 11.9 M | 12.9 M | 12.9 M | 12.9 M | 12.9 M | 5.98 M | 5.98 M | 5.98 M | 5.98 M | 3.23 M | 3.23 M | 3.23 M | 3.23 M | 2.64 M | 2.64 M | 2.64 M | 2.64 M |
Accounts Receivables |
95 M | 32.1 M | 297 M | 124 M | 395 M | 113 M | 82.4 M | 112 M | 195 M | 478 M | 455 M | 75.3 M | 50 M | 56.9 M | 262 M | 262 M | 262 M | 262 M | 7.5 M | 7.5 M | 7.5 M | 7.5 M | - | - | - | - | - | - | - | - | 233 K | 591 K | 363 K | 406 K | 2.32 M | 2.32 M | 2.32 M | 2.32 M | 7.51 M | 7.51 M | 7.51 M | 7.51 M | 1.91 M | 1.91 M | 1.91 M | 1.91 M | 1.01 M | 1.01 M | 1.01 M | 1.01 M | 1.96 M | 1.96 M | 1.96 M | 1.96 M |
Total Inventories |
8.64 M | 9.17 M | 41.7 M | 69.6 M | 23.5 M | 34.2 M | 36.7 M | 82.4 M | 256 M | 107 M | 8.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency